Kymera Therapeutics, Inc. (KYMR)
83.10
+4.87
(+6.23%)
USD |
NASDAQ |
Jun 11, 16:00
83.10
0.00 (0.00%)
After-Hours: 19:52
Kymera Therapeutics Shareholders Equity (Quarterly) : 1.540B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.540B |
| December 31, 2025 | 1.580B |
| September 30, 2025 | 946.26M |
| June 30, 2025 | 971.48M |
| March 31, 2025 | 786.23M |
| December 31, 2024 | 835.62M |
| September 30, 2024 | 892.93M |
| June 30, 2024 | 684.92M |
| March 31, 2024 | 711.20M |
| December 31, 2023 | 394.97M |
| September 30, 2023 | 395.54M |
| June 30, 2023 | 435.43M |
| March 31, 2023 | 462.00M |
| Date | Value |
|---|---|
| December 31, 2022 | 490.15M |
| September 30, 2022 | 512.88M |
| June 30, 2022 | 397.95M |
| March 31, 2022 | 428.72M |
| December 31, 2021 | 459.64M |
| September 30, 2021 | 483.14M |
| June 30, 2021 | 258.10M |
| March 31, 2021 | 275.25M |
| December 31, 2020 | 283.89M |
| September 30, 2020 | 294.68M |
| June 30, 2020 | 104.04M |
| March 31, 2020 | |
| December 31, 2019 | 34.67M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.500B |
| Erasca, Inc. | 393.53M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Sarepta Therapeutics, Inc. | 1.505B |
| Vir Biotechnology, Inc. | 812.76M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.669B |
| Total Liabilities (Quarterly) | 129.38M |
| Debt to Equity Ratio | 0.0523 |
| Current Ratio | 10.81 |
| Net Debt Paydown Yield | 0.02% |